Nuveen LLC Invests $50.67 Million in Encompass Health Corporation $EHC

Key Points

• Nuveen LLC has acquired 500,251 shares of Encompass Health Corporation, valued at approximately $50.7 million, representing 0.50% of the company.
• Encompass Health recently announced a quarterly dividend increase to $0.19 per share, with the ex-dividend date set for October 1st.
• The company reported earnings of $1.40 per share for the last quarter, exceeding analyst expectations, and exhibiting a 12% year-over-year revenue growth.

Nuveen LLC purchased a new position in shares of Encompass Health Corporation (NYSE:EHC - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 500,251 shares of the company's stock, valued at approximately $50,665,000. Nuveen LLC owned about 0.50% of Encompass Health as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the stock. Invesco Ltd. increased its position in shares of Encompass Health by 5.1% during the 1st quarter. Invesco Ltd. now owns 5,818,783 shares of the company's stock worth $589,326,000 after purchasing an additional 282,532 shares during the last quarter. T. Rowe Price Investment Management Inc. acquired a new position in shares of Encompass Health during the 4th quarter worth approximately $152,953,000. Price T Rowe Associates Inc. MD increased its position in shares of Encompass Health by 22.9% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 1,610,669 shares of the company's stock worth $148,746,000 after purchasing an additional 300,386 shares during the last quarter. Fuller & Thaler Asset Management Inc. increased its position in shares of Encompass Health by 24.8% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 1,378,077 shares of the company's stock worth $127,265,000 after purchasing an additional 274,192 shares during the last quarter. Finally, Northern Trust Corp increased its position in shares of Encompass Health by 21.4% during the 4th quarter. Northern Trust Corp now owns 1,032,901 shares of the company's stock worth $95,388,000 after purchasing an additional 182,076 shares during the last quarter. Institutional investors and hedge funds own 97.25% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on EHC shares. UBS Group lifted their target price on Encompass Health from $130.00 to $140.00 and gave the stock a "buy" rating in a research note on Wednesday, August 6th. Royal Bank Of Canada lifted their target price on Encompass Health from $110.00 to $125.00 and gave the stock an "outperform" rating in a research note on Monday, April 28th. Barclays lifted their target price on Encompass Health from $118.00 to $129.00 and gave the stock an "overweight" rating in a research note on Friday, April 25th. Truist Financial lifted their target price on Encompass Health from $135.00 to $140.00 and gave the stock a "buy" rating in a research note on Thursday, August 14th. Finally, Stephens upgraded Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 target price for the company in a research note on Thursday, June 5th. One analyst has rated the stock with a Strong Buy rating and six have assigned a Buy rating to the stock. According to data from MarketBeat, Encompass Health has an average rating of "Buy" and an average target price of $134.00.

Encompass Health Price Performance

Shares of NYSE:EHC traded up $1.53 during trading on Tuesday, reaching $121.75. 123,054 shares of the company traded hands, compared to its average volume of 815,857. The company's 50 day moving average is $116.13 and its two-hundred day moving average is $109.78. The firm has a market capitalization of $12.26 billion, a PE ratio of 23.83, a PEG ratio of 2.10 and a beta of 0.86. The company has a quick ratio of 1.06, a current ratio of 1.06 and a debt-to-equity ratio of 0.76. Encompass Health Corporation has a 52 week low of $87.85 and a 52 week high of $123.13.

Encompass Health (NYSE:EHC - Get Free Report) last released its earnings results on Monday, August 4th. The company reported $1.40 earnings per share for the quarter, beating analysts' consensus estimates of $1.20 by $0.20. The firm had revenue of $1.46 billion during the quarter, compared to the consensus estimate of $1.43 billion. Encompass Health had a return on equity of 17.83% and a net margin of 9.22%.The company's revenue was up 12.0% compared to the same quarter last year. During the same period in the prior year, the company posted $1.11 EPS. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. As a group, sell-side analysts predict that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be given a dividend of $0.19 per share. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Wednesday, October 1st. This is a positive change from Encompass Health's previous quarterly dividend of $0.17. Encompass Health's dividend payout ratio is currently 13.31%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.